Talis Biomedical Corporation
OTC: TLIS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Rebecca Markovich
- Employees
- 99
- Headquarters
- Menlo Park, United States
- IPO year
- 2021
- Market cap
- $5.2M
- Website
- https://talisbio.com
Loading TLIS…
Loading profile data…Frequently asked questions about TLIS
What does Talis Biomedical Corporation (TLIS) do?
Talis Biomedical Corporation specializes in molecular diagnostics, focusing on the creation of its Talis One system. This system is being developed to address and resolve existing limitations within current point-of-care diagnostic testing technologies for infectious diseases. The company currently provides the Talis One COVID-19 Test System, wh...
Where does TLIS trade?
Talis Biomedical Corporation (TLIS) trades on the Other OTC.
What sector is TLIS in?
Talis Biomedical Corporation (TLIS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Talis Biomedical Corporation?
Rebecca Markovich is the chief executive officer of Talis Biomedical Corporation (TLIS).
Where is Talis Biomedical Corporation headquartered?
Talis Biomedical Corporation is headquartered in United States.
Does TLIS pay a dividend?
Talis Biomedical Corporation (TLIS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TLIS go public?
Talis Biomedical Corporation (TLIS) completed its initial public offering in 2021.